Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Denosumab in the Prevention of Bone Loss in Non-menopausal Women With Anorexia Nervosa

NCT02567279 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT02567279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02567279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Denosumab in the Prevention of Bone Loss in Non-menopausal Women With Anorexia Nervosa
Lead sponsor
University Hospital, Montpellier
Phase
Phase 3
Overall status
Terminated
Start date
June 1, 2016
Completion date
January 3, 2019
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anorexia nervosa